Scientists have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought.
Verge Genomics, the drug discovery startup we recently featured in our Top 5 Startups Disrupting Healthcare, has raised $32 million in Series A financing.
Scientists have published one of the most detailed maps ever made of structural variations in a cancer cell’s genome.
Personalised medicine has been a goal of researchers and doctors for a long time. Now, researchers have developed what they call a personalised Therapeutic Intervention Fingerprint (pTIF), for patients with neurological disease.
Scientists have developed a technique that shows individual cancer cells in a tumour in real-time, revealing which cells that interact with a drug and which cells the drug fails to reach.
Researchers have created an artificial intelligence system for predicting, not simply tracking, potential side effects from drug combinations.
A new type of zebrafish that produces fluorescent tags in migratory embryonic nerve precursor cells could help researchers find the origins of the third-most common pediatric cancer in the U.S.
Researchers have for the first time, used gene-editing tools in adult monkeys to disable a gene throughout much of the liver.
Researchers have for the first time used a gene editing technique to successfully cure a genetic condition in a mouse model.
Researchers have developed a gentle, contact-free method that uses sound waves to separate circulating tumour cells from blood samples quickly and efficiently enough for clinical use.
New research could allow us greater control over what happens to genetically modified organisms once they’re in the wild.
CRISPR gene drives have been tested in laboratory mice for the first time, offering a way in which multiple genes in mice can be altered to model complex multigenic human diseases. Could this step eventually lead to the eradication of pest species or is the technology still too controversial?